Sterling Capital Management’s Albany Molecular Research Inc AMRI Stock Holding History

Sterling Capital Management’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-16,151	Closed	-$263K	–	1006
2014 Q4	$263K	Sell	16,151 -111,414	-87%	-$2.04M	﹤0.01%	857
2014 Q3	$2.82M	Sell	127,565 -324	-0.3%	-$6.63K	0.03%	269
2014 Q2	$2.57M	Buy	127,889 +6,465	+5%	+$110K	0.02%	274
2014 Q1	$2.26M	Buy	121,424 +91,489	+306%	+$1.26M	0.02%	299
2013 Q4	$302K	Buy	29,935 +6,274	+27%	+$75.8K	﹤0.01%	723
2013 Q3	$305K	Buy	+23,661	New	+$291K	﹤0.01%	576

Other funds holding AMRI

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIP

Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

OWP

Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

EWM

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Sterling Capital Management's AMRI Position: Q1 2015 in Review

Sterling Capital Management sold out of Albany Molecular Research Inc (AMRI) in Q1 2015, closing a stake of 16,151 shares — an estimated $263K sold.

Sterling Capital Management first reported a position in AMRI in Q3 2013 and held it in 6 quarters. The position peaked at $2.82M in Q3 2014. 131 funds tracked by Wall St. Rank hold AMRI as of Q1 2015.

Sterling Capital Management reported no remaining Albany Molecular Research Inc position as of Q1 2015 after selling out during the quarter.
Sterling Capital Management sold 16,151 Albany Molecular Research Inc shares in Q1 2015, an estimated $263K.
Sterling Capital Management first reported a position in Albany Molecular Research Inc in Q3 2013 and held it in 6 quarters.
Sterling Capital Management's Albany Molecular Research Inc position peaked at $2.82M in Q3 2014.
131 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2015.

Based on Sterling Capital Management's 13F filing for Q1 2015, filed 19 May 2015.